Table of Contents Author Guidelines Submit a Manuscript
Depression Research and Treatment
Volume 2011 (2011), Article ID 650450, 13 pages
http://dx.doi.org/10.1155/2011/650450
Review Article

Review: Magnetic Resonance Spectroscopy Studies of Pediatric Major Depressive Disorder

1The Brain Institute at the University of Utah, 383 Colorow Drive, Salt Lake City, UT 84108-1201, USA
2Department of Psychiatry, University of Utah School of Medicine, 30 N. 1900 E, Salt Lake City, UT 84132, USA
3Department of Radiology, University of Utah School of Medicine, 30 N. 1900 E, Salt Lake City, UT 84132, USA

Received 6 May 2010; Accepted 20 August 2010

Academic Editor: Bettina F. Piko

Copyright © 2011 Douglas G. Kondo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. K. Goodman, “Research on Biomarkers for Mental Disorders,” National Institute of Mental Health, Bethesda, Md, USA, 2009http://www.nimh.nih.gov/research-funding/grants/concept-clearances/2009/research-on-biomarkers-for-mental-disorders.shtml?WT.mc_id=rss.
  2. A. J. Atkinson Jr., W. A. Colburn, V. G. DeGruttola et al., “Biomarkers and surrogate endpoints: preferred definitions and conceptual framework,” Clinical Pharmacology and Therapeutics, vol. 69, no. 3, pp. 89–95, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. D. A. Regier, W. E. Narrow, E. A. Kuhl, and D. J. Kupfer, “The conceptual development of DSM-V,” American Journal of Psychiatry, vol. 166, no. 6, pp. 645–650, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. D. S. Charney, D. H. Barlow, K. Botterton, J. D. Cohen, D. Goldman, and R. E. Gur, “Neuroscience research agenda to guide development of a pathophysiologically based classification system,” in A Research Agenda for DSM-V, D. J. Kupfer, M. B. First, and D. A. Regier, Eds., American Psychiatric Publishing, Arlington, Va, USA, 2002. View at Google Scholar
  5. M. L. Phillips, “The emerging role of neuroimaging in psychiatry: characterizing treatment-relevant endophenotypes,” American Journal of Psychiatry, vol. 164, no. 5, pp. 697–699, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Singh and N. Rose, “Biomarkers in psychiatry,” Nature, vol. 460, no. 7252, pp. 202–207, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. E. Hyman, “Can neuroscience be integrated into the DSM-V?” Nature Reviews Neuroscience, vol. 8, no. 9, pp. 725–732, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. C. F. Reynolds III, D. A. Lewis, T. Detre, A. F. Schatzberg, and D. J. Kupfer, “The future of psychiatry as clinical neuroscience,” Academic Medicine, vol. 84, no. 4, pp. 446–450, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. N. Pavuluri and J. A. Sweeney, “Integrating functional brain neuroimaging and developmental cognitive neuroscience in child psychiatry research,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 47, no. 11, pp. 1273–1288, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Serene, M. Ashtari, P. R. Szeszko, and S. Kumra, “Neuroimaging studies of children with serious emotional disturbances: a selective review,” Canadian Journal of Psychiatry, vol. 52, no. 3, pp. 135–145, 2007. View at Google Scholar · View at Scopus
  11. A. J. Gerber and B. S. Peterson, “Applied brain imaging,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 47, no. 3, p. 239, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. W. C. Drevets, J. L. Price, and M. L. Furey, “Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression,” Brain Structure and Function, vol. 213, no. 1-2, pp. 93–118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Leibenluft, “Skating to where the puck will be: the importance of neuroimaging literacy in child psychiatry,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 47, no. 11, pp. 1213–1216, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. J. N. W. Friedman, R. A. Hurley, and K. H. Taber, “Bipolar disorder: imaging state versus trait,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 18, no. 3, pp. 296–301, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. M. A. H. Rot, S. J. Mathew, and D. S. Charney, “Neurobiological mechanisms in major depressive disorder,” Canadian Medical Association Journal, vol. 180, no. 3, pp. 305–313, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. World Health Organization, The Global Burden of Disease: 2004 Update, WHO Press, Geneva, Switzerland, 1st edition, 2008.
  17. R. C. Kessler, S. Avenevoli, J. Green et al., “National comorbidity survey replication adolescent supplement (NCS-A): III. concordance of DSM-IV/CIDI diagnoses with clinical reassessments,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 48, no. 4, pp. 386–399, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Paus, M. Keshavan, and J. N. Giedd, “Why do many psychiatric disorders emerge during adolescence?” Nature Reviews Neuroscience, vol. 9, no. 12, pp. 947–957, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Birmaher, D. Brent, W. Bernet, O. Bukstein, H. Walter, and R. S. Benson, “Practice parameter for the assessment and treatment of children and adolescents with depressive disorders,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 46, no. 11, pp. 1503–1526, 2007. View at Google Scholar
  20. P. M. Lewinsohn, H. Hops, R. E. Roberts, J. R. Seeley, and J. A. Andrews, “Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students,” Journal of Abnormal Psychology, vol. 102, no. 1, pp. 133–144, 1993. View at Publisher · View at Google Scholar · View at Scopus
  21. D. M. Fergusson, L. J. Horwood, E. M. Ridder, and A. L. Beautrais, “Subthreshold depression in adolescence and mental health outcomes in adulthood,” Archives of General Psychiatry, vol. 62, no. 1, pp. 66–72, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. F. L. Lynch and G. N. Clarke, “Estimating the economic burden of depression in children and adolescents,” American Journal of Preventive Medicine, vol. 31, no. 6, supplement 1, pp. 143–151, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. R. C. Kessler, S. Avenevoli, and K. Ries Merikangas, “Mood disorders in children and adolescents: an NIMH perspective,” Biological Psychiatry, vol. 49, no. 12, pp. 962–969, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Fombonne, G. Wostear, V. Cooper, R. Harrington, and M. Rutter, “The Maudsley long-term follow-up of child and adolescent depression: 2. Suicidality, criminality and social dysfunction in adulthood,” British Journal of Psychiatry, vol. 179, pp. 218–223, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Fombonne, G. Wostear, V. Cooper, R. Harrington, and M. Rutter, “The Maudsley long-term follow-up of child and adolescent depression: I. Psychiatric outcomes in adulthood,” British Journal of Psychiatry, vol. 179, pp. 210–217, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Vitiello, P. Rohde, S. Silva et al., “Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS),” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 45, no. 12, pp. 1419–1426, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. M. Weissman, S. Wolk, R. B. Goldstein et al., “Depressed adolescents grown up,” Journal of the American Medical Association, vol. 281, no. 18, pp. 1707–1713, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. E. M. Purcell, H. C. Torrey, and R. V. Pound, “Resonance absorption by nuclear magnetic moments in a solid,” Physical Review, vol. 69, no. 1-2, pp. 37–38, 1946. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Bloch, W. W. Hansen, and M. Packard, “Nuclear induction,” Physical Review, vol. 69, no. 3-4, p. 127, 1946. View at Publisher · View at Google Scholar · View at Scopus
  30. D. P. Soares and M. Law, “Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications,” Clinical Radiology, vol. 64, no. 1, pp. 12–21, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. E. R. Danielsen and B. Ross, Eds., Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases, Marcel Dekker, New York, NY, USA, 1st edition, 1999.
  32. T. Kato, T. Inubushi, and N. Kato, “Magnetic resonance spectroscopy in affective disorders,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 10, no. 2, pp. 133–147, 1998. View at Google Scholar · View at Scopus
  33. R. W. Prost, “Magnetic resonance spectroscopy,” Medical Physics, vol. 35, no. 10, pp. 4530–4544, 2008. View at Google Scholar
  34. N. Agarwal, J. D. Port, M. Bazzocchi, and P. F. Renshaw, “Update on the use of MR for assessment and diagnosis of psychiatric diseases,” Radiology, vol. 255, no. 1, pp. 23–41, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. R. A. de Graaf, In Vivo NMR Spectroscopy: Principles and Techniques, John Wiley & Sons, West Sussex, UK, 2nd edition, 2010.
  36. S. R. Dager, N. M. Corrigan, T. L. Richards, and S. Posse, “Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders,” Topics in Magnetic Resonance Imaging, vol. 19, no. 2, pp. 81–96, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Kreis, T. Ernst, and B. D. Ross, “Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy,” Magnetic Resonance in Medicine, vol. 30, no. 4, pp. 424–437, 1993. View at Publisher · View at Google Scholar · View at Scopus
  38. E. J. Novotny Jr., R. K. Fulbright, P. L. Pearl, K. M. Gibson, and D. L. Rothman, “Magnetic resonance spectroscopy of neurotransmitters in human brain,” Annals of Neurology, vol. 54, no. 6, supplement, pp. S25–S31, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. D. E. Bergles, J. S. Diamond, and C. E. Jahr, “Clearance of glutamate inside the synapse and beyond,” Current Opinion in Neurobiology, vol. 9, no. 3, pp. 293–298, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. C. M. Moore, J. Biederman, J. Wozniak et al., “Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex,” Journal of Affective Disorders, vol. 99, no. 1–3, pp. 19–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. D. L. Rothman, O. A. C. Petroff, K. L. Behar, and R. H. Mattson, “Localized 1H NMR measurements of γ-aminobutyric acid in human brain in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 12, pp. 5662–5666, 1993. View at Google Scholar · View at Scopus
  42. H. H. Tallan, S. Moore, and W. H. Stein, “N-Acetyl-L-aspartic acid in brain,” The Journal of Biological Chemistry, vol. 219, no. 1, pp. 257–264, 1956. View at Google Scholar
  43. E. E. Benarroch, “N-Acetylaspartate and N-acetylaspartylglutamate: neurobiology and clinical significance,” Neurology, vol. 70, no. 16, pp. 1353–1357, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. J. R. Moffett, B. Ross, P. Arun, C. N. Madhavarao, and A. M. A. Namboodiri, “N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology,” Progress in Neurobiology, vol. 81, no. 2, pp. 89–131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. G. J. Moore and M. P. Galloway, “Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders,” Psychopharmacology Bulletin, vol. 36, no. 2, pp. 5–23, 2002. View at Google Scholar · View at Scopus
  46. A. Yildiz-Yesiloglu and D. P. Ankerst, “Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 30, no. 6, pp. 969–995, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. S. D. Friedman, W. M. Brooks, R. E. Jung et al., “Quantitative proton MRS predicts outcome after traumatic brain injury,” Neurology, vol. 52, no. 7, pp. 1384–1391, 1999. View at Google Scholar · View at Scopus
  48. L. Kwock, J. K. Smith, M. Castillo et al., “Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer,” Lancet Oncology, vol. 7, no. 10, pp. 859–868, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. J. K. Smith, M. Castillo, and L. Kwock, “MR spectroscopy of brain tumors,” Magnetic Resonance Imaging Clinics of North America, vol. 11, no. 3, pp. 415–429, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Rosen and R. E. Lenkinski, “Recent advances in magnetic resonance neurospectroscopy,” Neurotherapeutics, vol. 4, no. 3, pp. 330–345, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Lopez-Villegas, R. E. Lenkinski, S. L. Wehrli, W.-Z. Ho, and S. D. Douglas, “Lactate production by human monocytes/macrophages determined by proton MR spectroscopy,” Magnetic Resonance in Medicine, vol. 34, no. 1, pp. 32–38, 1995. View at Publisher · View at Google Scholar · View at Scopus
  52. S. K. Gujar, S. Maheshwari, I. Björkman-Burtscher, and P. C. Sundgren, “Magnetic resonance spectroscopy,” Journal of Neuro-Ophthalmology, vol. 25, no. 3, pp. 217–226, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Frangou and S. C. R. Williams, “Magnetic resonance spectroscopy in psychiatry basic principles and applications,” British Medical Bulletin, vol. 52, no. 3, pp. 474–485, 1996. View at Google Scholar · View at Scopus
  54. G. K. Radda, “Control, bioenergetics, and adaptation in health and disease: noninvasive biochemistry from nuclear magnetic resonance,” FASEB Journal, vol. 6, no. 12, pp. 3032–3038, 1992. View at Google Scholar · View at Scopus
  55. L. Gyulai, L. Bolinger, and J. S. Leigh Jr., “Phosphorylethanolamine—the major constituent of the phosphomonoester peak observed by 31P-NMR on developing dog brain,” FEBS Letters, vol. 178, no. 1, pp. 137–142, 1984. View at Publisher · View at Google Scholar · View at Scopus
  56. T. Glonek, S. J. Kopp, and E. Kot, “P-31 nuclear magnetic resonance analysis of brain: the perchloric acid extract spectrum,” Journal of Neurochemistry, vol. 39, no. 5, pp. 1210–1219, 1982. View at Google Scholar · View at Scopus
  57. J. W. Pettegrew, S. J. Kopp, and N. J. Minshew, “31P nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: preliminary observations,” Journal of Neuropathology and Experimental Neurology, vol. 46, no. 4, pp. 419–430, 1987. View at Google Scholar · View at Scopus
  58. R. Reddy and M. S. Keshavan, “Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 69, no. 6, pp. 401–405, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. P. M. Kilby, N. M. Bolas, and G. K. Radda, “31P-NMR study of brain phospholipid structures in vivo,” Biochimica et Biophysica Acta, vol. 1085, no. 2, pp. 257–264, 1991. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Morikawa, T. Inubushi, K. Kitoh, C. Kido, and M. Nozaki, “Chemical assessment of phospholipid and phosphoenergetic metabolites in regenerating rat liver measured by in vivo and in vitro 31P-NMR,” Biochimica et Biophysica Acta, vol. 1117, no. 3, pp. 251–257, 1992. View at Publisher · View at Google Scholar · View at Scopus
  61. O. A. Petroff, J. W. Prichard, K. L. Behar, J. R. Alger, J. A. den Hollander, and R. G. Shulman, “Cerebral intracellular pH by 31P nuclear magnetic resonance spectroscopy,” Neurology, vol. 35, no. 6, pp. 781–788, 1985. View at Google Scholar
  62. M. Erecinska and I. A. Silver, “ATP and brain function,” Journal of Cerebral Blood Flow and Metabolism, vol. 9, no. 1, pp. 2–19, 1989. View at Google Scholar · View at Scopus
  63. P. F. Renshaw, A. M. Parow, F. Hirashima et al., “Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression,” American Journal of Psychiatry, vol. 158, no. 12, pp. 2048–2055, 2001. View at Publisher · View at Google Scholar · View at Scopus
  64. F. G. Webb, N. Sailasuta, S. J. Kohler, T. Raidy, R. A. Moats, and R. E. Hurd, “Automated single-voxel proton MRS: technical development and multisite verification,” Magnetic Resonance in Medicine, vol. 31, no. 4, pp. 365–373, 1994. View at Google Scholar · View at Scopus
  65. J. Alvarez-Linera, “3 T MRI: advances in brain imaging,” European Journal of Radiology, vol. 67, no. 3, pp. 415–426, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. I. K. Lyoo and P. F. Renshaw, “Magnetic resonance spectroscopy: current and future applications in psychiatric research,” Biological Psychiatry, vol. 51, no. 3, pp. 195–207, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. D. V. Iosifescu, N. R. Bolo, A. A. Nierenberg, J. E. Jensen, M. Fava, and P. F. Renshaw, “Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder,” Biological Psychiatry, vol. 63, no. 12, pp. 1127–1134, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. C. M. Moore, J. D. Christensen, B. Lafer, M. Fava, and P. F. Renshaw, “Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study,” American Journal of Psychiatry, vol. 154, no. 1, pp. 116–118, 1997. View at Google Scholar · View at Scopus
  69. H.-P. Volz, R. Rzanny, S. Riehemann et al., “31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients,” European Archives of Psychiatry and Clinical Neuroscience, vol. 248, no. 6, pp. 289–295, 1998. View at Publisher · View at Google Scholar · View at Scopus
  70. M. M. Chaumeil, J. Valette, M. Guillermier et al., “Multimodal neuroimaging provides a highly consistent picture of energy metabolism, validating 31P MRS for measuring brain ATP synthesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 10, pp. 3988–3993, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. R. C. Kessler, P. Berglund, O. Demler, R. Jin, K. R. Merikangas, and E. E. Walters, “Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication,” Archives of General Psychiatry, vol. 62, no. 6, pp. 593–602, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. R. H. Belmaker, “Bipolar disorder,” New England Journal of Medicine, vol. 351, no. 5, pp. 476–518, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. J. J. Mann, “The medical management of depression,” New England Journal of Medicine, vol. 353, no. 17, pp. 1819–1834, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. R. J. Steingard, D. A. Yurgelun-Todd, J. Hennen et al., “Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy,” Biological Psychiatry, vol. 48, no. 11, pp. 1053–1061, 2000. View at Publisher · View at Google Scholar · View at Scopus
  75. V. Kusumakar, F. P. MacMaster, L. Gates, S. J. Sparkes, and S. C. Khan, “Left medial temporal cytosolic choline in early onset depression,” Canadian Journal of Psychiatry, vol. 46, no. 10, pp. 959–964, 2001. View at Google Scholar · View at Scopus
  76. T. R. Farchione, G. J. Moore, and D. R. Rosenberg, “Proton magnetic resonance spectroscopic imaging in pediatric major depression,” Biological Psychiatry, vol. 52, no. 2, pp. 86–92, 2002. View at Publisher · View at Google Scholar · View at Scopus
  77. E. A. Smith, A. Russell, E. Lorch et al., “Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study,” Biological Psychiatry, vol. 54, no. 12, pp. 1399–1405, 2003. View at Publisher · View at Google Scholar · View at Scopus
  78. J. C. Soares, K. R. R. Krishnan, and M. S. Keshavan, “Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders,” Depression, vol. 4, no. 1, pp. 14–30, 1996. View at Publisher · View at Google Scholar · View at Scopus
  79. S.-T. Hong, C.-B. Choi, C. Park et al., “Variation of the choline signal intensity in the dorsolateral prefrontal cortex of rats exposed to the forced swimming test as detected by in vivo 1H MR spectroscopy,” Journal of Neuroscience Methods, vol. 165, no. 1, pp. 89–94, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. Y. Mirza, J. Tang, A. Russell et al., “Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 43, no. 3, pp. 341–348, 2004. View at Publisher · View at Google Scholar · View at Scopus
  81. D. R. Rosenberg, Y. Mirza, A. Russell et al., “Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 43, no. 9, pp. 1146–1153, 2004. View at Publisher · View at Google Scholar · View at Scopus
  82. D. R. Rosenberg, F. P. MacMaster, Y. Mirza et al., “Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study,” Biological Psychiatry, vol. 58, no. 9, pp. 700–704, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. S. C. Caetano, M. Fonseca, R. L. Olvera et al., “Proton spectroscopy study of the left dorsolateral prefrontal cortex in pediatric depressed patients,” Neuroscience Letters, vol. 384, no. 3, pp. 321–326, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. F. P. MacMaster and V. Kusumakar, “Choline in pediatric depression,” McGill Journal of Medicine, vol. 9, no. 1, pp. 24–27, 2006. View at Google Scholar · View at Scopus
  85. Y. Mirza, J. O'Neill, E. A. Smith et al., “Increased medial thalamic creatine- phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls,” Journal of Child Neurology, vol. 21, no. 2, pp. 106–111, 2006. View at Publisher · View at Google Scholar · View at Scopus
  86. V. Gabbay, D. A. Hess, S. Liu, J. S. Babb, R. G. Klein, and O. Gonen, “Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study,” American Journal of Psychiatry, vol. 164, no. 12, pp. 1881–1889, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. F. P. MacMaster, G. J. Moore, A. Russell et al., “Medial temporal N-acetyl-aspartate in pediatric major depression,” Psychiatry Research, vol. 164, no. 1, pp. 86–89, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. V. Gabbay, R. G. Klein, C. M. Alonso et al., “Immune system dysregulation in adolescent major depressive disorder,” Journal of Affective Disorders, vol. 115, no. 1-2, pp. 177–182, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. V. Gabbay, L. Liebes, Y. Katz et al., “The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 34, no. 1, pp. 37–44, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. P. M. Lewinsohn, P. Rohde, J. R. Seeley, D. N. Klein, and I. H. Gotlib, “Natural course of adolescent major depressive disorder in a community sample: predictors of recurrence in young adults,” American Journal of Psychiatry, vol. 157, no. 10, pp. 1584–1591, 2000. View at Publisher · View at Google Scholar · View at Scopus
  91. R. L. Hendren, I. De Backer, and G. J. Pandina, “Review of neuroimaging studies of child and adolescent psychiatric disorders from the past 10 years,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 39, no. 7, pp. 815–828, 2000. View at Google Scholar · View at Scopus
  92. D. J. Kupfer, M. B. First, and D. A. Regier, A Research Agenda for DSM-V, American Psychiatric Publishing, Washington, DC, USA, 1st edition, 2002.
  93. M. L. Phillips and E. Frank, “Redefining bipolar disorder: toward DSM-V,” American Journal of Psychiatry, vol. 163, no. 7, pp. 1135–1136, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. J. A. Stanley, “In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders,” Canadian Journal of Psychiatry, vol. 47, no. 4, pp. 315–326, 2002. View at Google Scholar · View at Scopus
  95. E. Fuchs, B. Czéh, M. H. P. Kole, T. Michaelis, and P. J. Lucassen, “Alterations of neuroplasticity in depression: the hippocampus and beyond,” European Neuropsychopharmacology, vol. 14, supplement 5, pp. S481–S490, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. A. S. Gonul, O. Kitis, E. Ozan et al., “The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 30, no. 1, pp. 120–125, 2006. View at Publisher · View at Google Scholar · View at Scopus
  97. B. P. Forester, D. G. Harper, J. E. Jensen et al., “31Phosphorus magnetic resonance spectroscopy study of tissue specific changes in high energy phosphates before and after sertraline treatment of geriatric depression,” International Journal of Geriatric Psychiatry, vol. 24, no. 8, pp. 788–797, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. G. F. Mason and J. H. Krystal, “MR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases,” NMR in Biomedicine, vol. 19, no. 6, pp. 690–701, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. H. C. Kraemer, G. T. Wilson, C. G. Fairburn, and W. S. Agras, “Mediators and moderators of treatment effects in randomized clinical trials,” Archives of General Psychiatry, vol. 59, no. 10, pp. 877–883, 2002. View at Google Scholar · View at Scopus
  100. P. F. Renshaw, B. Lafer, S. M. Babb et al., “Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study,” Biological Psychiatry, vol. 41, no. 8, pp. 837–843, 1997. View at Publisher · View at Google Scholar · View at Scopus
  101. C. Stork and P. F. Renshaw, “Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research,” Molecular Psychiatry, vol. 10, no. 10, pp. 900–919, 2005. View at Publisher · View at Google Scholar · View at Scopus
  102. J. E. Jensen, M. Daniels, C. Haws et al., “Triacetyluridine (TAU) decreases depressive symptoms and increases brain pH in bipolar patients,” Experimental and Clinical Psychopharmacology, vol. 16, no. 3, pp. 199–206, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. P. F. Renshaw and I. K. Lyoo, “Creatine Augmentation Treatment in Major Depressive Disorder Subjects,” US National Library of Medicine, Bethesda, Md, USA, http://clinicaltrials.gov/ct2/show/NCT00729755.
  104. W. A. Carlezon Jr., A. M. Pliakas, A. M. Parow, M. J. Detke, B. M. Cohen, and P. F. Renshaw, “Antidepressant-like effects of cytidine in the forced swim test in rats,” Biological Psychiatry, vol. 51, no. 11, pp. 882–889, 2002. View at Publisher · View at Google Scholar · View at Scopus
  105. W. A. Carlezon Jr., S. D. Mague, A. M. Parow, A. L. Stoll, B. M. Cohen, and P. F. Renshaw, “Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats,” Biological Psychiatry, vol. 57, no. 4, pp. 343–350, 2005. View at Publisher · View at Google Scholar · View at Scopus
  106. P. J. Allen, K. E. D'Anci, P. F. Renshaw, and R. B. Kararek, Dietary Creatine Supplementation: A New Model of Depression?Society for Neuroscience, Washington, DC, USA, 2008.
  107. P. J. Allen, K. E. D'Anci, R. B. Kanarek, and P. F. Renshaw, “Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner,” Neuropsychopharmacology, vol. 35, pp. 534–546, 2009. View at Publisher · View at Google Scholar · View at Scopus
  108. T. Kato and N. Kato, “Mitochondrial dysfunction in bipolar disorder,” Bipolar Disorders, vol. 2, no. 3, pp. 180–190, 2000. View at Google Scholar · View at Scopus
  109. D. V. Iosifescu and P. F. Renshaw, “31P-Magnetic resonance spectroscopy and thyroid hormones in major depressive disorder: toward a bioenergetic mechanism in depression?” Harvard Review of Psychiatry, vol. 11, no. 2, pp. 51–63, 2003. View at Publisher · View at Google Scholar · View at Scopus
  110. T. Kato, “Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications,” CNS Drugs, vol. 21, no. 1, pp. 1–11, 2007. View at Google Scholar · View at Scopus
  111. L. Shao, M. V. Martin, S. J. Watson et al., “Mitochondrial involvement in psychiatric disorders,” Annals of Medicine, vol. 40, no. 4, pp. 281–295, 2008. View at Publisher · View at Google Scholar · View at Scopus
  112. K. Chang, N. Adleman, C. Wagner, N. Barnea-Goraly, and A. Garrett, “Will neuroimaging ever be used to diagnose pediatric bipolar disorder?” Development and Psychopathology, vol. 18, no. 4, pp. 1133–1146, 2006. View at Publisher · View at Google Scholar · View at Scopus
  113. Y. Goto, C. R. Yang, and S. Otani, “Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders,” Biological Psychiatry, vol. 67, no. 3, pp. 199–207, 2009. View at Publisher · View at Google Scholar · View at Scopus
  114. H. K. Manji, J. A. Quiroz, J. Sporn et al., “Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression,” Biological Psychiatry, vol. 53, no. 8, pp. 707–742, 2003. View at Publisher · View at Google Scholar · View at Scopus
  115. S. J. Mathew, H. K. Manji, and D. S. Charney, “Novel drugs and therapeutic targets for severe mood disorders,” Neuropsychopharmacology, vol. 33, no. 9, pp. 2080–2092, 2008. View at Publisher · View at Google Scholar · View at Scopus
  116. P. J. Carlson, J. B. Singh, C. A. Zarate Jr., W. C. Drevets, and H. K. Manji, “Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets,” NeuroRx, vol. 3, no. 1, pp. 22–41, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. H. K. Manji, W. C. Drevets, and D. S. Charney, “The cellular neurobiology of depression,” Nature Medicine, vol. 7, no. 5, pp. 541–547, 2001. View at Publisher · View at Google Scholar · View at Scopus
  118. R. S. Duman, G. R. Heninger, and E. J. Nestler, “A molecular and cellular theory of depression,” Archives of General Psychiatry, vol. 54, no. 7, pp. 597–606, 1997. View at Google Scholar · View at Scopus
  119. G. Sanacora, G. F. Mason, D. L. Rothman et al., “Reduced cortical γ-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy,” Archives of General Psychiatry, vol. 56, no. 11, pp. 1043–1047, 1999. View at Publisher · View at Google Scholar · View at Scopus
  120. T. A. Klempan, A. Sequeira, L. Canetti et al., “Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression,” Molecular Psychiatry, vol. 14, no. 2, pp. 175–189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  121. G. Rajkowska, G. O'Dwyer, Z. Teleki, C. A. Stockmeier, and J. J. Miguel-Hidalgo, “GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression,” Neuropsychopharmacology, vol. 32, no. 2, pp. 471–482, 2007. View at Publisher · View at Google Scholar · View at Scopus
  122. G. Sanacora and A. Saricicek, “GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant action,” CNS and Neurological Disorders, vol. 6, no. 2, pp. 127–140, 2007. View at Publisher · View at Google Scholar · View at Scopus
  123. G. Sanacora, R. Gueorguieva, C. N. Epperson et al., “Subtype-specific alterations of γ-aminobutyric acid and glutamate in patients with major depression,” Archives of General Psychiatry, vol. 61, no. 7, pp. 705–713, 2004. View at Publisher · View at Google Scholar · View at Scopus
  124. D. A. Yurgelun-Todd, S. Sava, and M. K. Dahlgren, “Mood Disorders,” Neuroimaging Clinics of North America, vol. 17, no. 4, pp. 511–521, 2007. View at Publisher · View at Google Scholar · View at Scopus
  125. A. J. Gerber and B. S. Peterson, “What is an image?” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 47, no. 3, pp. 245–248, 2008. View at Publisher · View at Google Scholar · View at Scopus
  126. H. S. Mayberg, “Limbic-cortical dysregulation: a proposed model of depression,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 9, no. 3, pp. 471–481, 1997. View at Google Scholar · View at Scopus
  127. P. Davanzo, K. Yue, M. A. Thomas et al., “Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents,” American Journal of Psychiatry, vol. 160, no. 8, pp. 1442–1452, 2003. View at Publisher · View at Google Scholar · View at Scopus
  128. C. M. Moore, J. Biederman, J. Wozniak et al., “Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study,” American Journal of Psychiatry, vol. 163, no. 2, pp. 316–318, 2006. View at Publisher · View at Google Scholar · View at Scopus
  129. N. Carrey, F. P. MacMaster, J. Fogel et al., “Metabolite changes resulting from treatment in children with ADHD: a 1H-MRS study,” Clinical Neuropharmacology, vol. 26, no. 4, pp. 218–221, 2003. View at Publisher · View at Google Scholar · View at Scopus
  130. N. Carrey, F. P. MacMaster, S. J. Sparkes, S. C. Khan, and V. Kusumakar, “Glutamatergic changes with treatment in attention deficit hyperactivity disorder: a preliminary case series,” Journal of Child and Adolescent Psychopharmacology, vol. 12, no. 4, pp. 331–336, 2002. View at Publisher · View at Google Scholar · View at Scopus
  131. P. A. Bottomley, “The trouble with spectroscopy papers,” Radiology, vol. 181, no. 2, pp. 344–350, 1991. View at Google Scholar · View at Scopus
  132. R. Kreis, “Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts,” NMR in Biomedicine, vol. 17, no. 6, pp. 361–381, 2004. View at Publisher · View at Google Scholar · View at Scopus
  133. J. S. Taylor, “The trouble with spectroscopy papers, 15 years later,” NMR in Biomedicine, vol. 19, no. 4, pp. 409–410, 2006. View at Publisher · View at Google Scholar · View at Scopus
  134. A. R. Tate, J. Underwood, D. M. Acosta et al., “Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra,” NMR in Biomedicine, vol. 19, no. 4, pp. 411–434, 2006. View at Publisher · View at Google Scholar · View at Scopus
  135. M. van der Graaf, M. Julià-Sapé, F. A. Howe et al., “MRS quality assessment in a multicentre study on MRS-based classification of brain tumours,” NMR in Biomedicine, vol. 21, no. 2, pp. 148–158, 2008. View at Publisher · View at Google Scholar · View at Scopus
  136. J. M. Garcia-Gomez, J. Luts, M. Julia-Sape et al., “Multiproject-multicenter evaluation of automatic brain tumor classification by magnetic resonance spectroscopy,” Magnetic Resonance Materials in Physics, Biology and Medicine, vol. 22, no. 1, pp. 5–18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  137. T. Kato, S. Takahashi, T. Shioiri, and T. Inubushi, “Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy,” Journal of Affective Disorders, vol. 26, no. 4, pp. 223–230, 1992. View at Publisher · View at Google Scholar · View at Scopus
  138. P. Davanzo, M. A. Thomas, K. Yue et al., “Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder,” Neuropsychopharmacology, vol. 24, no. 4, pp. 359–369, 2001. View at Publisher · View at Google Scholar · View at Scopus
  139. M. P. DelBello, K. M. Cecil, C. M. Adler, J. P. Daniels, and S. M. Strakowski, “Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study,” Neuropsychopharmacology, vol. 31, no. 6, pp. 1264–1273, 2006. View at Publisher · View at Google Scholar · View at Scopus
  140. N. C. Patel, M. P. DelBello, K. M. Cecil et al., “Lithium treatment effects on myo-inositol in adolescents with bipolar depression,” Biological Psychiatry, vol. 60, no. 9, pp. 998–1004, 2006. View at Publisher · View at Google Scholar · View at Scopus
  141. N. C. Patel, M. P. DelBello, K. M. Cecil, K. E. Stanford, C. M. Adler, and S. M. Strakowski, “Temporal change in N-acetyl-aspartate concentrations in adolescents with bipolar depression treated with lithium,” Journal of Child and Adolescent Psychopharmacology, vol. 18, no. 2, pp. 132–139, 2008. View at Publisher · View at Google Scholar · View at Scopus
  142. K. Chang, A. Karchemskiy, R. Kelley et al., “Effect of divalproex on brain morphometry, chemistry, and function in youth at high-risk for bipolar disorder: a pilot study,” Journal of Child and Adolescent Psychopharmacology, vol. 19, no. 1, pp. 51–59, 2009. View at Publisher · View at Google Scholar · View at Scopus
  143. D. P. Dickstein, K. E. Towbin, J. W. Van Der Veen et al., “Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation,” Journal of Child and Adolescent Psychopharmacology, vol. 19, no. 1, pp. 61–73, 2009. View at Publisher · View at Google Scholar · View at Scopus